Dreem Acquisition, Valuation, Funding & Investors
Dreem was acquired by Sunrise in February 2024.
Dreem acquisition price
Undisclosed
Acquired by Sunrise · Feb 2024
Cumulative funding Dreem raised
$57M
across 3 funding rounds
Key investors in Dreem
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 20 20"><rect fill="%23e5e7eb" width="20" height="20" rx="4"/></svg>)
Xavier NielMAIF Avenir
- Laurent Alexandre
Bpifrance
Johnson & Johnson
About Dreem
Dreem is a neurotechnology company producing wearable headbands to improve sleep quality. The device analyzes brainwaves, monitors sleep stages, and uses audio stimulation to extend deep sleep periods. Headquartered in Paris with operations in the United States, Dreem focuses on consumer products enhancing daily performance.
Dreem Acquisition
Dreem was acquired by Sunrise for an undisclosed price on 22 February 2024.
Before the acquisition Dreem had raised $57M across 3 funding rounds.
Belgium-based Sunrise, a leader in proprietary sleep disorder diagnostics technology featuring an FDA-approved chin patch home sleep test that analyzes mandibular jaw movements, acquired Dreem Health, a California-based digital sleep clinic offering telemedicine consultations, diagnostics, and personalized treatment for sleep conditions like apnea. Dreem Health, launched by sleep tech company Dreem, maintains partnerships with major insurers including Aetna, UnitedHealthcare, and Medicare, enabling insured, convenient care across 49 U.S. states. The 2024 acquisition, with undisclosed financial terms, integrates Sunrise's diagnostic tools with Dreem Health's infrastructure to provide end-to-end telehealth services, bypassing costly traditional polysomnography studies. Strategically, the deal marks Sunrise's U.S. market entry and expansion into all 50 states, aiming to democratize affordable sleep care, become the largest U.S. sleep clinic by 2025, and drive significant revenue growth amid rising sleep disorder prevalence. To support scaling, Sunrise appointed Laura Warnier, former growth leader at EdTech firm GoStudent, as Chief Growth Officer to build sales and marketing teams. The move follows Sunrise's prior €17 million funding and over $35 million total capital from investors like Amazon’s Alexa Fund, Kurma Partners, and VIVES Partners, with subsequent $29 million raised in 2025 for nationwide and international expansion including AI investments and studies validating test accuracy against polysomnography.
| Acquirer | Date | Type |
|---|---|---|
| 22 Feb 2024 | Strategic M&A |
Dreem Valuation
Dreem is currently valued at $1B, based on its Series A in June 2017.
The $11M round included Xavier Niel, Laurent Alexandre and MAIF Avenir.
Dreem valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Jun 2017 | Series A | $1B |
Dreem Funding History
Dreem has raised a total of $57M across 3 funding rounds.
Dreem's first fundraising round was a $11M Series A in March 2016. The most recent completed round was a $35M undisclosed-stage round in June 2018.
Dreem funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Jun 2018 | Undisclosed stage | Bpifrance (lead); Johnson & Johnson (lead); Xavier Niel; MAIF Avenir | $35M | - | Dreem is a Paris and San Francisco-based sleep technology company founded to combine neuroscience with advanced technology to help improve sleep quality. The company offers a lightweight headband (120 grams) equipped with EEG sensors that measure brain activity, respiratory rate, and heart rate, combined with bone induction sound that allows the device to communicate with users without disturbing others. Dreem's technology orchestrates background sounds in step with the user's body to help induce and maintain deep sleep. In June 2018, Dreem raised €31 million from healthcare company Johnson & Johnson, French public investment bank Bpifrance, and early backers, bringing total funding raised to €53 million. The company was led by co-founder and CEO Hugo Mercier and employed a team of over 70 sleep researchers and engineers. Following the funding round, Dreem announced the addition of Professor Russell Foster from Oxford's Nuffield Laboratory of Ophthalmology and Dr. Raphael Heinzer from Lausanne's Centre Intégré de Recours to its scientific advisory board to strengthen its research and clinical capabilities. |
| Jun 2017 | Series A | Xavier Niel; Laurent Alexandre; MAIF Avenir | $11M | $1B | DT Dream (also referred to as Dreem) completed a Series A funding round on June 8, 2017, achieving a valuation of $1,000 million. The round amount is undisclosed in available data. No specific investors matching Laurent Alexandre, MAIF Avenir, or Xavier Niel are listed for this round; sources mention general investor activity without naming them here. |
| Mar 2016 | Series A | Xavier Niel; Laurent Alexandre | $11M | - | - |
Who has invested in Dreem?
5 investors have backed Dreem across its funding rounds, including Xavier Niel, MAIF Avenir, Laurent Alexandre, Bpifrance and Johnson & Johnson.
Lead investors include Bpifrance and Johnson & Johnson.
Dreem Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| Xavier Niel |  Paris | 3 | Participant | Mar 2016 |
| Laurent Alexandre |  Brussels | 2 | Participant | Mar 2016 |
| France | 2 | Participant | Jun 2017 | |
This data is available for Pro users. Sign up to see all 5 Dreem investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialDreem Competitors
Dreem competitors include listed companies like HTC and Yunding Technology, and private ones like Forward, Huami, XPANCEO and Lanmi.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
 San Francisco, CA | Private | - | - | $1B | - | |
 Taiwan | Publicly listed | $91M | $22M | $1B | 6.9x | |
 China | Publicly listed | $228M | $22M | $884M | - | |
| Beijing | Private | $41M | - | $800M | 19.5x | |
 Dubai | Private | - | - | $1.4B | - | |
| Dongguan | Private | - | - | $716M | - |
Dreem Public Comps
Dreem is no longer listed, but its public comps include HTC, Yunding Technology, Catapult, Vuzix, Angel Robotics, Mitac Digital Technology, Xplora, Zepp Health, Mobvoi and GN Store Nord.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $91M | $22M | 6.8x | 6.9x | 27.7x | (6.2x) | |||
| $228M | $22M | 3.6x | - | 37.9x | - | |||
| $141M | $15M | 4.3x | 4.0x | 40.8x | 20.6x | |||
| $6M | ($29M) | 35.9x | 33.9x | (7.7x) | - | |||
| $3M | ($6M) | 61.7x | - | (33.3x) | - | |||
| $261M | $14M | 0.2x | 0.2x | 4.4x | - | |||
| $204M | $14M | 0.9x | 0.9x | 12.4x | 7.6x | |||
| $259M | ($27M) | 0.9x | 0.8x | (9.0x) | (29.3x) | |||
This data is available for Pro users. Sign up to see all Dreem competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Dreem
| When was Dreem founded? | Dreem was founded in 2014. |
| Where is Dreem headquartered? | Dreem is headquartered in San Francisco, CA, United States. |
| Is Dreem publicly listed? | No, Dreem was acquired by Sunrise in February 2024. |
| Who acquired Dreem? | Dreem was acquired by Sunrise in February 2024. |
| What is Dreem's valuation? | Dreem was last valued at $1B in its Series A in June 2017. |
| How much funding has Dreem raised? | Dreem has raised $57M across 3 funding rounds. |
| What was Dreem's last funding round? | Dreem's last funding round was a $35M undisclosed-stage round in June 2018, led by Bpifrance and Johnson & Johnson. |
| Who are Dreem's investors? | Dreem's investors include Xavier Niel, Laurent Alexandre, MAIF Avenir, Bpifrance and Johnson & Johnson. |
| Which companies are comparable to Dreem? | Companies comparable to Dreem include Forward, HTC, Yunding Technology, Huami, XPANCEO and Lanmi. |
See companies similar to Dreem
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.